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Introduction {#sec1}
============

Cells simultaneously contain several actin-based structures that need to be tailored to their specific function, with a specific architecture, size, lifetime, and set of actin-binding proteins. The architecture is defined in part by the nucleator \[[@bib1], [@bib2]\]: Arp2/3 promotes the assembly of branched structures, whereas other nucleators, in particular formins, assemble linear ones. Arp2/3-assembled dendritic networks generate pushing forces against membranes, for instance in the lamellipodium of migrating cells, to drive the movement of intracellular bacteria, or to promote internalization of endocytic vesicles in yeast actin patches. Formin-nucleated actin structures consist of linear filaments, which can be bundled for protrusive or contractile force generation, for instance in filopodia or cytokinetic contractile rings, or which underlie long-range myosin-based transport.

The principles underlying the assembly of distinct actin structures at the same time are beginning to be understood. First, competition is an important factor. For instance, diverse filamentous actin (F-actin) structures are in competition for a limited pool of actin monomers \[[@bib3]\]. This competition is modulated by profilin, which favors F-actin assembly by formins and other nucleators over Arp2/3 \[[@bib4], [@bib5]\]. Second, specific actin nucleators confer part of the structure's identity: formins promote the formation of more flexible filaments \[[@bib6]\], favoring tropomyosin association \[[@bib7]\]; different formins may even promote association of distinct tropomyosin isoforms \[[@bib8]\]. Third, self-assembly principles govern the segregation of specific actin-binding proteins to diverse structures. For instance, cooperative loading and competition between fimbrin and tropomyosin drive their association to distinct actin structures \[[@bib9]\]. Therefore, *in vivo*, tropomyosin preferentially associates with formin-assembled structures and fimbrin with Arp2/3-nucleated actin patches \[[@bib10], [@bib11]\].

Capping protein (CP) is present in cells in micromolar concentration, similar to the concentration of actin filament barbed ends, and binds the barbed end to arrest dynamics \[[@bib12]\]. CP forms a heterodimer of structurally similar α and β subunits, both of which harbor a mobile C-terminal extension, called the tentacle, which contributes to barbed-end binding \[[@bib13], [@bib14], [@bib15]\]. CP lacking both tentacles forms a stable complex but does not bind actin, with the α tentacle playing a more critical role than the β tentacle \[[@bib14], [@bib16]\]. CP activity is further regulated by binding partners bearing a CP interaction (CPI) motif \[[@bib17]\]: CP-carrying mutations blocking CPI binding retain capping activity *in vitro* but lose localization and function *in vivo*, indicating that binding partners are required for activity *in vivo* \[[@bib18]\]. The Aim21-Tda2 complex, which binds CP through the same residues, modulates CP recruitment and activity at actin patches in *S. cerevisiae* \[[@bib19], [@bib20]\]. By keeping filaments short, CP plays a major role in the force production of dendritic networks \[[@bib21]\]. Indeed, absence of CP leads to loss of the lamellipodium in migrating cells \[[@bib22], [@bib23]\] and excess actin filaments in yeast actin patches, which exhibit a longer lifetime \[[@bib16], [@bib24], [@bib25], [@bib26]\].

As formins and CP both interact with actin filament barbed ends but promote opposite activities---i.e., extension versus capping---they compete with each other *in vitro* \[[@bib27], [@bib28], [@bib29], [@bib30]\]. Recent single-molecule work showed formin and CP simultaneously binding the filament barbed end, forming a ternary "decision complex" intermediate \[[@bib31], [@bib32]\]. Evidence for competition *in vivo* was shown in the fission yeast *Schizosaccharomyces pombe*, where CP deletion ameliorates the cell-division phenotype of a hypomorphic formin *cdc12* allele \[[@bib33]\]. CP may also compete with formins in filopodia \[[@bib34]\]. In addition, CP is well established to compete with ENA/VASP both *in vitro* and *in vivo*, where this competition controls filopodium formation \[[@bib12], [@bib35]\]. Whether such competition contributes to actin structure identity has not been explored.

The fission yeast represents a simple system to dissect the mechanisms governing actin structure identities. This cell contains only four actin structures, actin patches, cables, ring, and focus, each of which fulfils a specific function \[[@bib1], [@bib36]\]. Arp2/3 nucleates actin patches, marked by fimbrin Fim1, around invaginating endocytic vesicles, which assemble in a stereotypical manner \[[@bib37], [@bib38]\] and provide force for vesicle internalization \[[@bib39]\]. CP localizes to actin patches \[[@bib33], [@bib40], [@bib41]\], where it limits actin incorporation and helps force production \[[@bib16], [@bib24], [@bib25], [@bib26]\]. Interestingly, although active CP is a heterodimer, deletion of the α and β subunits (Acp1 and Acp2, respectively) does not produce exactly the same phenotype \[[@bib24]\]. Three formins nucleate distinct linear F-actin structures: Cdc12 assembles the contractile actin ring; For3 assembles linear actin cables that underlie long-range myosin-based transport for polarized cell growth; and Fus1 is expressed specifically during mating and nucleates the fusion focus, an F-actin aster that concentrates secretory vesicles transported by myosin V Myo52 \[[@bib42], [@bib43]\]. These vesicles carry cell-wall hydrolases, which digest the cell wall for cell fusion. The coalescence of the fusion focus also requires tropomyosin Cdc8 \[[@bib44]\], and a visual screen revealed Cdc8 functions together with the type V myosin Myo51 \[[@bib45]\]. This same screen identified fusion defects in cells lacking *acp2*.

Starting from the hypothesis that CP and formin Fus1 compete during fusion focus assembly, we discovered that CP protects actin patches against formin activity. In the absence of CP, Fus1 binds barbed ends in actin patches, forming ectopic foci that divert secretory vesicles away from the site of cell-cell contact and compromise fusion. Similarly, in proliferating cells lacking CP, the formins For3 and Cdc12 are ectopically recruited to actin patches, which exhibit a dual identity manifested by co-decoration with fimbrin and tropomyosin. Thus, CP ensures actin structure identity by insulating Arp2/3-assembled structures against formins.

Results {#sec2}
=======

Capping Protein Is Required for Efficient Cell-Cell Fusion {#sec2.1}
----------------------------------------------------------

To investigate the role of CP in cell fusion, we first assessed the fusion efficiency of strains lacking one or both CP subunits (*acp1Δ*, *acp2Δ*, *acp1Δ acp2Δ*). After 12 h of starvation, these strains exhibited a reduced fraction of fused zygotes compared to wild type (WT), which increased 36 h post starvation ([Figure 1](#fig1){ref-type="fig"}A), indicating that CP deletion causes a fusion delay. The duration of the fusion process, from initial formation of the Myo52-labeled fusion focus in both partner cells \[[@bib42]\] to cytoplasmic mixing, defined by entry in the M cell of cytosolic GFP expressed in P cells, was significantly longer in CP-lacking cells ([Figures 1](#fig1){ref-type="fig"}B and 1C). The fusion focus also persisted significantly longer post fusion in CP-lacking cells ([Figures 1](#fig1){ref-type="fig"}D and 1E). Both phenotypes were clear in all mutant combinations but strongest in *acp2Δ* single mutant, on which we focused most of our attention. Thus, CP promotes fusion, because its absence causes fusion delay and persistence of the fusion focus after fusion.Figure 1CP Deletion Leads to Fusion Delay and Fusion Focus Persistence after Fusion(A) Fusion efficiencies 12 and 36 h after nitrogen removal in the indicated strains.(B) Fusion times in the indicated strains.(C) Time-lapse images of Myo52-tdTomato and cytosolic GFP expressed in P cells under the *map3* promoter in WT and *acp2*Δ, from the beginning to end of the fusion process. The times shown (in h:min) are relative to the initial formation of the fusion focus.(D) Time-lapse images of strains as in (C) from the time of fusion taking place up to the disappearance of the fusion focus. The times shown (in h:min) are relative to the time of fusion. Note that the first image (at 00:00) is the same as the last image in (C).(E) Fusion focus persistence times in the indicated strains.All indicated p values are relative to WT. Scale bars represent 5 μm.

Formin Fus1 and F-Actin Excessively Accumulate at the Fusion Site in the Absence of Capping Protein {#sec2.2}
---------------------------------------------------------------------------------------------------

Consistent with CP preventing filament barbed-end extension, previous work reported that Arp2/3-assembled actin patches lacking CP accumulate more actin \[[@bib24], [@bib41]\]. To investigate the organization of F-actin during fusion, we first used GFP-CHD as F-actin marker \[[@bib46], [@bib47]\]. Like in interphase cells, actin patches appeared brighter in *acp2Δ* than WT cells during mating ([Figure 2](#fig2){ref-type="fig"}A) \[[@bib24]\]. *acp2Δ*, *acp1*Δ, and *acp1*Δ *acp2*Δ cells also displayed slightly more F-actin at the position of the fusion focus ([Figures 2](#fig2){ref-type="fig"}A, 2D, and [S1](#mmc1){ref-type="supplementary-material"}A). Because GFP-CHD measurements at the fusion site cannot distinguish between F-actin in the fusion focus or in surrounding patches, we probed the localization of specific fusion focus components. Fus1 accumulated approximately 4-fold more in *acp2*Δ, *acp1*Δ, and *acp1*Δ *acp2*Δ cells than in WT cells at the fusion focus ([Figures 2](#fig2){ref-type="fig"}B, 2D, and [S1](#mmc1){ref-type="supplementary-material"}B). Global Fus1-sfGFP fluorescence levels also increased 1.6-fold ([Figure S1](#mmc1){ref-type="supplementary-material"}D). Tropomyosin Cdc8, which preferentially binds formin-assembled filaments \[[@bib7], [@bib44], [@bib48], [@bib49], [@bib50]\], increased about 2-fold at the fusion focus of *acp2*Δ compared to WT cells ([Figures 2](#fig2){ref-type="fig"}C, 2D, and [S1](#mmc1){ref-type="supplementary-material"}C). Thus, the absence of CP leads to increased F-actin and associated proteins at the fusion focus.Figure 2CP Deletion Leads to Increased Actin, Tropomyosin, and Fus1 at the Fusion Focus(A--C) Myo52-tdTomato and (A) GFP-CHD labeling F-actin, (B) Fus1-sfGFP, and (C) GFP-Cdc8 in WT and *acp2*Δ at fusion time.(D) Fusion focus fluorescence intensities normalized to WT at fusion time in strains as in (A)--(C). See [Figures S1](#mmc1){ref-type="supplementary-material"}A--S1C for full fluorescence profile measurements.(E) Spinning-disk confocal images of Myo52-tdTomato and WT or mutant Fus1-sfGFP, as indicated, in WT and *acp2*Δ. Yellow arrowheads point to unfused cell pairs, with a broad Fus1 and Myo52 distribution at the contact zone. Blue arrowheads point to fusion foci.(F) Fusion efficiencies at 9 h after nitrogen removal in WT or *acp2*Δ strains carrying WT or mutant *fus1*, as indicated.All p values are relative to WT, except where indicated. Scale bars represent 5 μm. See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

The dramatic Fus1 increase in *acp2Δ* fusion foci is consistent with the proposed competition between formins and CP for barbed-end binding \[[@bib31], [@bib32], [@bib33]\]. We note that CP levels were mildly increased in *fus1*Δ (1.1-fold; [Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B). To probe the hypothesis that CP promotes cell fusion by limiting Fus1-driven actin polymerization at the fusion focus, we tested whether (1) Fus1 overexpression mimics loss of CP, (2) reducing Fus1 activity ameliorates fusion efficiency in the absence of CP, and (3) CP localizes to the fusion focus. First, Fus1 overexpression had no effect on fusion duration, fusion focus persistence, or ectopic Myo52 foci ([Figures S2](#mmc1){ref-type="supplementary-material"}C--S2E; see below regarding ectopic foci). However, the overexpression increased total Fus1 but not Fus1 at the fusion focus ([Figure S2](#mmc1){ref-type="supplementary-material"}D). Thus, Fus1 overexpression does not directly mimic loss of CP. Second, we constructed four Fus1 alleles mutated in the FH2 domain. Although all mutants abolished actin assembly *in vitro* \[[@bib51]\], they showed different phenotypes when introduced as sole copy at the native genomic locus of otherwise WT cells. Fus1^K879A^ and Fus1^K1112A^, which carry mutations in the FH2 lasso, were partly fusion competent, whereas Fus1^I951A^ and Fus1^G1087R,N1088P^, which carry mutations in the FH2 knob and post, respectively, almost completely blocked cell fusion. Combining these *fus1* alleles with the *acp2*Δ phenotype did not systematically ameliorate the fusion phenotype ([Figures 2](#fig2){ref-type="fig"}E and 2F). In particular, the two hypomorphic lasso mutants compromised fusion further in *acp2*Δ. By contrast, the fusion-incompetent *fus1*^*I951A*^ allele permitted high levels of fusion in *acp2Δ*. This reveals an allele-specific suppression, where the Fus1 knob but not lasso mutants compromise competition with CP. This finding is consistent with the recently proposed steric clash between the FH2 knob and the CP β tentacle \[[@bib31]\]. Third, Acp1 and Acp2 tagged with sfGFP localized prominently to actin patches, but neither was detected at the fusion focus in either WT cells or cells lacking the other CP subunit ([Figures 5](#fig5){ref-type="fig"}A, 5C, 5D, and 5F). Thus, CPs are largely absent from the fusion focus, suggesting that competition with Fus1 principally takes place elsewhere.

Absence of Capping Protein Leads to Reduced Levels of Myosin V and Cargoes at the Fusion Focus and Formation of Ectopic Foci {#sec2.3}
----------------------------------------------------------------------------------------------------------------------------

Despite higher Fus1 levels, myosin Myo52 was reduced about 2-fold at the fusion focus in *acp2*Δ compared to WT cells ([Figures 1](#fig1){ref-type="fig"}C and [3](#fig3){ref-type="fig"}F). A similar reduction was observed in *acp1Δ* and *acp1Δ acp2Δ* cells ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Similarly, exocytic vesicles marked by the exocyst subunits Exo84 and Exo70, the Rab11 homolog Ypt3, and the glucanase cargoes Agn2 and Eng2 were all reduced at the focus at fusion time in CP-lacking strains ([Figures 3](#fig3){ref-type="fig"}A--3F and [S3](#mmc1){ref-type="supplementary-material"}B--S3F). Because these glucanases are responsible for degrading the cell wall for fusion \[[@bib42]\], their reduced accumulation at the focus is the likely cause of the *acp2*Δ fusion delay.Figure 3CP Deletion Leads to Reduced Vesicular Markers at the Fusion Focus and Formation of Ectopic Foci(A--E) Myo52-tdTomato and (A) Exo84-GFP, (B) Exo70-GFP, (C) GFP-Ypt3, (D) Agn2-sfGFP, and (E) Eng2-sfGFP in WT and *acp2*Δ before fusion time. White arrows highlight ectopic foci. Note that these images, selected to show ectopic foci, stem from various time points during time-lapse imaging, for which specific timing in the fusion process and photobleaching may mask the difference in fusion focus intensity.(F) Fusion focus fluorescence intensities at fusion time normalized to WT in the strains mentioned in (A)--(E).(G) Time-lapse images of Myo52-tdTomato in WT and *acp2Δ* during the fusion process. White arrows show ectopic Myo52 foci. Time is in h:min.(H) Number of time frames at which a Myo52 ectopic focus was observed during the fusion process in time-lapse imaging as in (G).All p values are relative to WT. Scale bars represent 5 μm. See also [Figure S3](#mmc1){ref-type="supplementary-material"} and [Video S1](#mmc2){ref-type="supplementary-material"}.

Why do the actin-rich *acp2Δ* fusion foci accumulate fewer exocytic vesicles? We noticed that *acp2*Δ cells frequently form Myo52 foci away from the fusion focus ([Figure 3](#fig3){ref-type="fig"}G). Such ectopic foci formed in both P and M cells repeatedly during the fusion process. In time-lapse imaging at 5-min intervals, *acp2*Δ cells displayed on average 7 time points with ectopic foci, *acp1*Δ and *acp1*Δ *acp2*Δ cells displayed 1, and we barely found any for WT cells with this set-up (a single ectopic focus in 32 mating pairs; [Figure 3](#fig3){ref-type="fig"}H). Camera upgrade (which happened in the course of the project) and spinning-disk imaging revealed more ectopic foci in all backgrounds, including WT (see [Figures 5](#fig5){ref-type="fig"}J and [4](#fig4){ref-type="fig"}A, respectively). The rare, transient ectopic foci detected in WT mating pairs (see [Figure 1](#fig1){ref-type="fig"}C, 10-min time frames, for example) suggest that the *acp2*Δ behavior exists but is normally repressed in WT cells. These ectopic foci extensively colocalized with Exo84, Exo70, and Ypt3 ([Figures 3](#fig3){ref-type="fig"}A--3C and [S3](#mmc1){ref-type="supplementary-material"}G--S3I). We could not detect glucanases at ectopic foci, likely because of low expression levels and reduction of function by sfGFP tagging ([Figures 3](#fig3){ref-type="fig"}D and 3E). These results suggest that the formation of ectopic foci is the cause of the reduced Myo52 and cargoes at the fusion focus.Figure 4Myo52 Ectopic Foci Form at Actin Patches(A) Spinning-disk confocal time-lapse images of Myo52-tdTomato and cytosolic GFP expressed under the *map3* promoter (shown only for the first time point) in WT and *acp2*Δ before fusion time. The white arrow marks an ectopic Myo52 focus that forms at 1 s and then moves toward the fusion focus. Time is in min:s. Right: number of time points, acquired at 1-s intervals during 3 min, displaying a Myo52 ectopic focus.(B--E) Spinning-disk confocal images of Myo52-tdTomato and (B) Exo70-GFP, (C) GFP-CHD, (D) Myo51-sfGFP, and (E) Fus1-sfGFP in WT and *acp2*Δ before fusion time.(F and G) Spinning-disk confocal images of strains expressing Fim1-mCherry and (F) Myo51-sfGFP or (G) Fus1-sfGFP in WT and *acp2*Δ before fusion time.The bar plots to the right of the images show the proportion of ectopic foci colocalizing with the indicated markers, of which an example is shown with a white arrow. Scale bars represent 5 μm. See also [Figure S4](#mmc1){ref-type="supplementary-material"} and [Videos S2](#mmc3){ref-type="supplementary-material"}, [S3](#mmc4){ref-type="supplementary-material"}, and [S4](#mmc5){ref-type="supplementary-material"}.

Myo52 Ectopic Foci Form at Actin Patches {#sec2.4}
----------------------------------------

Higher-speed time-lapse spinning-disk imaging at 1-s intervals showed Myo52 ectopic foci did not appear randomly: they did not break off from the fusion focus; instead, they formed and stayed at remote locations at the cell periphery, occasionally moving back and fusing with the fusion focus ([Figure 4](#fig4){ref-type="fig"}A; [Video S1](#mmc2){ref-type="supplementary-material"}). The colocalization with exocytic markers stood true at this higher temporal resolution ([Figure 4](#fig4){ref-type="fig"}B). Thus, ectopic foci are nucleated at a remote location in the absence of CP.

Video S1. Formation of Myo52 Ectopic Focus and Movement toward the Fusion Focus in *acp2Δ*, Related to Figure 3Spinning-disk confocal microscopy time-lapse of Myo52-tdTomato and cytosolic GFP expressed under the *map3* promoter in WT and *acp2Δ* before fusion time. Time is in min:s. The Video is sped up 7x. Bars are 5μm.

Interestingly, GFP-CHD as F-actin marker revealed that \>90% of ectopic foci colocalized, at least transiently, with what looked like actin patches ([Figure 4](#fig4){ref-type="fig"}C). Ectopic foci also colocalized with Myo51, a second type V myosin that normally associates with tropomyosin and decorates linear actin structures \[[@bib45], [@bib52], [@bib53]\] ([Figure 4](#fig4){ref-type="fig"}D). Whereas Myo51 principally decorates the fusion focus in WT cells, in *acp2Δ* it additionally localized to actin patches marked by the actin bundler Fim1 \[[@bib54], [@bib55]\] ([Figure 4](#fig4){ref-type="fig"}F). Importantly, the more sensitive spinning-disk microscopy also revealed Fus1 in Myo52 ectopic foci ([Figure 4](#fig4){ref-type="fig"}E; [Video S2](#mmc3){ref-type="supplementary-material"}), which colocalized with Fim1 ([Figure 4](#fig4){ref-type="fig"}G; [Video S3](#mmc4){ref-type="supplementary-material"}). Fus1 also colocalized with Myo52 ectopic foci in *acp1Δ acp2Δ* double mutants ([Figure S4](#mmc1){ref-type="supplementary-material"}; [Video S4](#mmc5){ref-type="supplementary-material"}). Thus, the absence of CP leads to recruitment of formin Fus1 and type V myosin to Arp2/3-nucleated actin patches.

Video S2. Coincidence of Fus1 and Myo52 at Ectopic Foci in *acp2Δ*, Related to Figure 4Spinning-disk confocal microscopy time-lapse of Fus1-sfGFP and Myo52-tdTomato in WT and *acp2Δ* before fusion time. Time is in min:s. The Video is sped up 7x. Bars are 5μm.

Video S3. Localization of Fus1 Ectopic Foci at Fim1-Labeled Actin Patches in *acp2Δ*, Related to Figure 4Spinning-disk confocal microscopy time-lapse of Fus1-sfGFP and Fim1-mCherry in WT and *acp2Δ* before fusion time. Time is in min:s. The Video is sped up 7x. Bars are 5μm.

Video S4. Coincidence of Fus1 and Myo52 at Ectopic Foci in *acp1Δ acp2Δ*, Related to Figure 4Spinning-disk confocal microscopy time-lapse of Fus1-sfGFP and Myo52-tdTomato in WT and *acp1Δ acp2Δ* before fusion time. Time is in min:s. The Video is sped up 7x. Bars are 5μm.

Fus1 likely binds exposed filament barbed ends at actin patches in the absence of CP, and nucleates ectopic foci. To investigate whether CP's capping function is required to protect patches from Fus1, we deleted Acp1 and Acp2 tentacles (*acp1*^Δ*t*^ and *acp2*^Δ*t*^) to reduce CP affinity for actin barbed ends. These truncations compromised actin patch localization, with Acp2^Δt^ retaining better localization than Acp1^Δt^ ([Figures 5](#fig5){ref-type="fig"}B, 5E, and 5H), in agreement with previous *in vitro* work \[[@bib14]\]. They also showed more frequent ectopic Myo52 foci than WT cells, in an order consistent with their retained actin-binding capacity ([Figures 5](#fig5){ref-type="fig"}B, 5E, and 5I). We also generated *acp2*^*R12A,Y77A*^, predicted not to bind the CPI motif \[[@bib18]\]. Acp2^R12A,Y77A^ localized inefficiently to patches ([Figures 5](#fig5){ref-type="fig"}G and 5H), and exhibited ectopic foci and increased fusion times, to levels intermediate between WT and *acp2*Δ cells ([Figure 5](#fig5){ref-type="fig"}J). The reduced localization of Acp1^Δt^, Acp2^Δt^, and Acp2^R12A,Y77A^ to actin patches was not due to reduced F-actin content in the patches, which instead exhibited increased LifeAct-mCherry fluorescence ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B), like *acp2Δ* cells \[[@bib24]\]. These results indicate that localization of CP to patches is necessary to prevent the formation of ectopic foci.Figure 5CP Recruitment to Actin Patches and Barbed-End Binding Is Required to Protect against Ectopic Foci(A--G) Myo52-tdTomato- (A) Acp1-sfGFP, (B) Acp1^Δt^-sfGFP, (C) Acp1-sfGFP in *acp2Δ*, (D) Acp2-sfGFP, (E) Acp2^Δt^-sfGFP, (F) Acp2-sfGFP in *acp1Δ*, or (G) Acp2^R12A,Y77A^, carrying mutated CPI-interacting residues, at fusion time, as indicated. Scale bars represent 5 μm.(H) Acp1-sfGFP and Acp2-sfGFP patch-to-cytosol fluorescence intensity ratios in fusing cells of strains as in (A)--(G).(I) Number of time frames at which a Myo52 ectopic focus was observed during the fusion process in time-lapse imaging of strains as in (A)--(F).(J) Ectopic foci (as in I) and fusion times for WT (*acp2-sfGFP*), *acp2*^*R12A,Y77A*^*-sfGFP*, and *acp2*Δ strains.All p values are relative to WT. See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

Finally, to test whether ectopic foci cause the fusion delay by diverting vesicles away from the cell-cell contact zone, we artificially recruited Myo52-GFP to patches labeled with Fim1-GBP-mCherry by using the high affinity between GFP-binding protein (GBP) and GFP ([Figures S5](#mmc1){ref-type="supplementary-material"}C--S5E). This led to fusion delay and focus persistence after fusion, replicating the *acp2*Δ phenotypes ([Figures 1](#fig1){ref-type="fig"}B, 1E, and [S5](#mmc1){ref-type="supplementary-material"}C--S5E).

We conclude that during fusion, CP insulates actin patches from Fus1. This ensures Fus1 activity is restricted, and myosin V-driven cargoes are directed, to the site of cell-cell contact.

Uncapped Actin Patches Recruit Formins and Acquire a Dual Identity in Interphase Cells {#sec2.5}
--------------------------------------------------------------------------------------

To test whether CP more generally protects actin patch identity, we investigated the influence of CP deletion in interphase cells. In the absence of CP, actin patches are dispersed both in *S. cerevisiae* \[[@bib56]\] and in *S. pombe* \[[@bib24], [@bib41]\], and *S. pombe* cells also exhibit weak actin cables \[[@bib33], [@bib41]\]. Remarkably, markers normally associated with formin-nucleated actin cables were perturbed in *acp2Δ*: Myo51, which labels cable-like structures in WT cells \[[@bib53]\], formed punctate structures that colocalized with Fim1 in *acp2*Δ cells ([Figure 6](#fig6){ref-type="fig"}A); Myo52, which mainly localizes to cell tips in WT cells, formed dots that coincided with Myo51 and Fim1 patches in *acp2*Δ ([Figures 6](#fig6){ref-type="fig"}B and 6C); and tropomyosin Cdc8, which stabilizes actin cables and is largely absent from actin patches in WT cells, formed foci that colocalized with Fim1 in *acp2*Δ ([Figure 6](#fig6){ref-type="fig"}D; [Video S5](#mmc6){ref-type="supplementary-material"}). The coincidence of fimbrin and tropomyosin is particularly remarkable given recent data showing that competition between these two proteins drives their sorting to distinct Arp2/3- and formin-nucleated networks, respectively \[[@bib9]\]. Thus, actin patches assume a dual identity in the absence of CP both during mating and during vegetative growth.Figure 6CPs Insulate Actin Patches from Myo52 and Actin Cable Markers in Interphase Cells(A--F) Spinning-disk confocal images of (A) Fim1-mCherry and Myo51-sfGFP, (B) Myo52-tdTomato and Myo51-sfGFP, (C) Myo52-tdTomato and Fim1-sfGFP, (D) Fim1-mCherry and GFP-Cdc8, (E) Fim1-mCherry and For3-3GFP, and (F) Fim1-mCherry and Cdc12-3GFP in WT and *acp2Δ* interphase cells. In (E), bottom panels show *acp2Δ* treated with 500 μM CK-666 for 5 min or 200 μM latrunculin A for 5 min. White arrows highlight colocalization events in *acp2Δ*, which do not occur in WT cells. Yellow arrowheads point to Cdc12 spots. The proportion of colocalization at ectopic sites along the cell sides is shown with the bar plot on the right.(G) Spinning-disk confocal time-lapse images of Fim1-mCherry and For3-3GFP (green and gray) showing retrograde flow in WT (top) and *acp2Δ* cells (bottom two panels). Bottom: an example of retrograde flow starting at a lateral actin patch. Kymographs of the yellow dashed boxed regions are shown on the right. Green arrows point to For3-3GFP retrograde flow. Purple arrowheads in kymographs show lateral actin patches on which For3 localizes in *acp2Δ* but not WT cells.(H) For3 retrograde flow rate.Time is in s. Scale bars represent 5 μm. See also [Figure S6](#mmc1){ref-type="supplementary-material"} and [Videos S5](#mmc6){ref-type="supplementary-material"} and [S6](#mmc7){ref-type="supplementary-material"}.

Video S5. Colocalization of Tropomyosin Cdc8 and Fimbrin in *acp2Δ* Interphase Cells, Related to Figure 6Spinning-disk confocal microscopy time-lapse of GFP-Cdc8 and Fim1-mCherry in WT and *acp2Δ* in exponentially growing cells. Time is in min:s. The Video is sped up 7x. Bars are 5μm.

Because Fus1 is not expressed during mitotic growth \[[@bib43]\], we monitored the localization of For3 and Cdc12 formins. For3, which only occasionally overlapped with actin patches in WT cells, was prominently present at actin patches in *acp2Δ* mutants ([Figure 6](#fig6){ref-type="fig"}E; [Video S6](#mmc7){ref-type="supplementary-material"}). By contrast, in *fim1Δ* cells, in which tropomyosin also decorates patches \[[@bib11]\], For3 was largely absent from patches like in WT cells ([Figure S6](#mmc1){ref-type="supplementary-material"}A). In *acp2Δ* cells, disruption of patches with the Arp2/3 inhibitor CK-666 or F-actin depolymerization with latrunculin A restored For3 localization to cell poles ([Figure 6](#fig6){ref-type="fig"}E). Arp2/3 inhibition also promoted Fim1 re-localization to cell poles, which is likely due to excess formin-assembled cables \[[@bib3]\], as complete actin depolymerization rendered Fim1 cytosolic ([Figure 6](#fig6){ref-type="fig"}E). Thus, uncapped actin patches ectopically recruit For3. Cdc12 also formed ectopic foci at actin patches in *acp2Δ* cells ([Figure 6](#fig6){ref-type="fig"}F). These ectopic foci were distinct from the previously reported spot of Cdc12 \[[@bib57]\], which also occurs in WT cells, does not coincide with patches, has a longer lifetime, and is more intense ([Figure 6](#fig6){ref-type="fig"}F). We conclude that formins are recruited to uncapped actin patches.

Video S6. Localization of For3 at Fim1-Labeled Actin Patches in *acp2Δ* Interphase Cells, Related to Figure 6Spinning-disk confocal microscopy time-lapse of For3-3GFP and Fim1-mCherry in WT and *acp2Δ* in exponentially growing cells. Time is in min:s. The Video is sped up 7x. Bars are 5μm.

To address whether formins are active at patches, we first tested whether their inactivation would alleviate the localization of tropomyosin at *acp2Δ* actin patches. However, deletion of *for3* by itself led to significant Cdc8 enrichment on actin patches, likely because actin cytoskeleton homeostasis is perturbed in the absence of actin cables ([Figure S6](#mmc1){ref-type="supplementary-material"}B). Therefore, not surprisingly, Cdc8 also localized to actin patches in *for3Δ acp2Δ* and *cdc12-112 for3Δ acp2Δ* mutants ([Figures S6](#mmc1){ref-type="supplementary-material"}B and S6C). We then directly probed for For3 activity by observing its retrograde flow, which depends on actin assembly in cables \[[@bib47]\]. For3 retrograde flow occurred at similar rates in WT and *acp2Δ* cells, although fewer movements were observed in *acp2Δ*, consistent with the weak actin cables ([Figures 6](#fig6){ref-type="fig"}G and 6H) \[[@bib33], [@bib41]\]. Interestingly, For3 linear movements could be observed to initiate from actin patches, suggesting cable assembly from the patches ([Figure 6](#fig6){ref-type="fig"}G). We conclude that, independent of the specific formin, CP insulates actin patches from formins, restricting their activity to the proper location.

Discussion {#sec3}
==========

How cells simultaneously assemble functionally diverse actin structures of distinct identity within a common cytosol is a debated question. Arp2/3 and formins, respectively, assemble branched and linear actin structures decorated by largely distinct actin-binding proteins. A hallmark of formins is their ability to promote barbed-end growth against the growth-arrest function of CP, a feature demonstrated in numerous *in vitro* studies \[[@bib27], [@bib28], [@bib29], [@bib30], [@bib31], [@bib32]\]. However, how CP may prevail against formins *in vivo* was largely unexplored. Here, we have shown that CP protects Arp2/3-assembled actin patches against formins, thus preserving their identity and restricting formins to their proper location.

Our interest in CP arose from the cell-fusion delay of *acp2Δ* cells. For fusion, cells locally digest their cell wall by concentrating the exocytosis of secretory vesicles containing cell-wall hydrolase at the site of cell-cell contact \[[@bib42]\]. In WT cells, this is achieved by the Fus1-assembled actin fusion focus. By contrast, in cells lacking CP, despite strong Fus1 accumulation at the fusion site, secretory vesicles are frequently diverted away from the fusion site to ectopic Fus1 foci at actin patches. This correlates with a reduction in secretory vesicles at the fusion focus, which likely explains the fusion delay. Indeed, the forced diversion of Myo52 to actin patches also yields extended fusion times. Thus, the fusion defect of CP mutants likely results from diversion of secretory vesicles to ectopic sites, rather than from excessive actin assembly at the fusion site. Because CP mutants exhibit longer actin patch lifetimes \[[@bib24]\], which may lead to slower endocytosis, the fusion delay may also partly result from reduced recycling of the pheromone receptor from the plasma membrane \[[@bib58]\].

This raises the question of where CP acts---in formin-assembled structures or at Arp2/3-assembled patches. We argue that the formin-CP competition happens throughout the cell, with distinct outcomes: in formin-assembled structures, the formin wins and CP is largely dispensable; at actin patches, CP dominates and insulates this structure against formins. These distinct outcomes are reflected in the exclusive localization of CP at patches and restriction of formins to other cellular locations. The occasional ectopic foci detected in WT cells illustrate that CP patch protection against formins is an active process that can transiently fail even in WT cells.

CP-formin competition is best revealed by alteration of Fus1 and/or CP function. At the fusion focus, the competition is exposed by Fus1 FH2 mutations. A first observation is that FH2 mutations compromise fusion to various extents *in vivo*, although they all fully abrogated actin assembly *in vitro* \[[@bib51]\]. The poor predictive value of the *in vitro* activity may be due to high local Fus1 concentration in the focus, which likely exceeds the concentrations tested *in vitro*. A second observation is the strong allele-specific suppression by *acp2Δ* of the fusion defect of *fus1*^*I951A*^, which carries a mutation in the knob. This allele-specific suppression is consistent with the proposed structural arrangement of the formin-CP ternary complex at the barbed end, which shows a steric clash between the formin knob and CPβ \[[@bib31]\]. The I951A mutation likely favors the binding of CPβ, thus promoting capping function in the ternary complex, which is relieved upon CPβ deletion. In the cell, the inability of Fus1^I951A^ to assemble a fusion focus must be due to CP competing with the formin at the fusion site. Further evidence for competition at this location comes from increased Fus1 intensity at the fusion focus and the extended focus lifetime in CP mutants. This suggests that small amounts (below detection levels) of CP may compete with Fus1 in the fusion focus, although the increased Fus1 intensity may also be due to Fus1 recruitment to adjacent patches. We conclude that some Fus1-CP competition can take place at the fusion site, where Fus1 normally dominates.

Our data indicate that the principal sites of formin-CP competition are actin patches, where CP efficiently outcompetes Fus1. In WT cells, CP is strongly enriched at actin patches and prevents formin binding. In cells lacking CP function, all three formins localize to actin patches. The strength of CP protection against formins largely scales with its barbed-end binding affinity as measured *in vitro* \[[@bib14]\], with *acp2*^*Δt*^ showing fewer ectopic foci than *acp1*^*Δt*^, and *acp1Δ* or *acp2Δ*. When CP is absent from patches, these acquire characteristics of linear actin structures: they are decorated by myosin V Myo51 and tropomyosin, which normally preferentially associate with actin cables, ring, and focus \[[@bib7], [@bib44], [@bib45], [@bib48], [@bib49], [@bib50], [@bib52], [@bib53]\]; they also accumulate the myosin V Myo52, which erroneously transports its cargoes to these locations. The coincidence of tropomyosin and fimbrin at patches devoid of CP is striking given recent findings that competition between these actin-binding proteins drives their specific association with formin- and Arp2/3-assembled structure *in vitro*, respectively \[[@bib9], [@bib10], [@bib11]\]. Importantly, For3 is absent from tropomyosin-decorated *fim1Δ* patches, indicating that formins localize to patches because of a specific defect in capping rather than a global change in actin cytoskeleton homeostasis. We conclude that, in the absence of CP, actin patches acquire a double identity.

One important question is whether the double identity of CP-devoid patches arises from ectopic formin activity or simply from uncapping. This question is difficult to address because any perturbation in actin structures will perturb homeostasis \[[@bib3]\]. For instance, formin deletion frees G-actin and tropomyosin, which now incorporate in actin patches. Conversely, actin patch disruption enhances formin-assembled structures, now more permissive for fimbrin association. However, two observations argue for formin activity at CP-devoid patches. First, during mating, Myo52 was not present at all actin patches, but was always there when Fus1 was. This argues that Fus1 activity is the driving force for vesicular cargo recruitment. Second, the For3 flow from patches indicates assembly of cables from this location \[[@bib47]\]. As a side note, although the mechanism and function of For3 retrograde flow remain unknown, it occurred, and at similar rates, in *acp2Δ* cells, indicating that flow is not due to arrest of For3-dependent filament elongation upon formation of a ternary formin-CP complex. Together, these observations indicate that patch-localized formins actively assemble linear actin filaments.

An interesting observation is that *acp2Δ* cells consistently displayed stronger phenotypes not only than *acp1Δ* but also than *acp1Δ acp2Δ* double mutants. Berro and Pollard also previously noted that the phenotypes of *acp2Δ* and *acp1Δ* are not identical \[[@bib24]\]. We note that our data show a quantitative, but not qualitative, difference between these genotypes. It is formally possible that the stronger phenotype of *acp2Δ* cells is due to a CPβ function partly unrelated to capping activity. However, the weaker phenotype of *acp1Δ acp2Δ* instead indicates that Acp1 not bound by Acp2 enhances the phenotype. One interpretation is that, although formins gain access to actin barbed ends in the absence of Acp2, they may gain better access if Acp1 is still present. Because Acp1 still weakly binds the actin barbed end in the absence of Acp2 *in vitro* \[[@bib16]\], its presence may somehow help recruit formins to the barbed end. This interpretation predicts an interaction between formins and CPα, a hypothesis consistent with human INF2 formin association with CPα \[[@bib59]\].

Because CP-formin competition yields distinct outcomes at the sites of formin action and Arp2/3-assembled patches, one question is what defines the competition outcome. Part of the answer comes from the Acp2^R12A,Y77A^ allele, carrying mutations in the CPI-binding residues, which compromises CP localization to actin patches. This finding agrees with previous data in human cells that CP localization relies on interaction with CPI-containing proteins \[[@bib18]\]. The specific CP-binding partners are unknown in *S. pombe*, but may involve the homolog of *S. cerevisiae* Aim21, which binds CP through the CPI-binding residues and contributes to its localization to actin patches \[[@bib19]\], although this finding was not reproduced in a second study \[[@bib20]\]. Consistent with this hypothesis, deletion of *S. pombe* Aim21 was identified in our genome-wide screen to have fusion defects \[[@bib45]\]. The phenotype of *acp2*^*R12A,Y77A*^ cells indicates that CP recruitment to actin patches by pre-localized partners is required to protect them against formin activity. Thus, barbed-end-independent recruitment of CP may tip the CP-formin competition in favor of CP in Arp2/3-assembled structures.

The findings described in our study present the CP-formin competition in a new light, where CP protects Arp2/3 structures against ectopic localization of formins. In fission yeast *acp2*Δ cells, formin localization to actin patches has important consequences for cellular organization: during mating, Fus1 diverts cargoes away from the fusion site, slowing the fusion process; in interphase cells, For3 activity at patches may cause the previously noted actin cable disorganization and partial loss of cell polarity, leading to actin patch depolarization \[[@bib24], [@bib33]\]; in dividing cells, the reason for the cytokinetic defect of cells lacking CP \[[@bib33]\] may also be the titration of Cdc12 to actin patches. Because CP is ubiquitous in eukaryotic cells, it likely protects the identity of Arp2/3 actin assemblies and prevents formin ectopic activity in a vast range of organisms.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Chemicals, Peptides, and Recombinant Proteins**LatrunculinAEnzo Life ScienceCat\# T-119-0500CK666SigmaCat\# SML0006AgaPure Agarose LECanvaxCat\# AG006VaselinReactolabCat\# 99813LanolinSigmaCat\# L7387ParaffinReactolabCat\# 99756Dimethyl sulfoxide (DMSO)ApplichemCat\# 1584Poly(ethylene glycol) BioUltra, 4,000SigmaCat\# 95904Lithium Acetat DihydratApplichemCat\# A3478EDTA Disodium Salt 2-hydrateApplichemCat\# A2937Tris(hydroxymethyl)aminomethaneBiosolveCat\# 200923**Experimental Models: Organisms/Strains***h90 myo52-tdTomato:natMX ura4-294:p*^*map3*^*-GFP:ura4+*Lab StockYSM2535*h90 myo52-tdTomato:natMX ura4-294:p*^*map3*^*-GFP-ura4+ acp1::kanMX*Lab StockYSM3307*h90 myo52-tdTomato:natMX ura4-294:p*^*map3*^*-GFP-ura4+ acp2::kanMX*Lab StockYSM2955*h90 myo52-tdTomato:natMX ura4-294:p*^*map3*^*-GFP-ura4+ acp1::kanMX acp2::kanMX*This workYSM3308*h90 myo52-tdTomato:natMX leu1-32:p*^*nmt41*^*-GFP-CHD:leu1*^*+*^Lab StockYSM2515*h90 myo52-tdTomato:natMX leu1-32:p*^*nmt41*^*-GFP-CHD:leu1*^*+*^*acp1::hphMX*This workYSM3309*h90 myo52-tdTomato:natMX leu1-32:p*^*nmt41*^*-GFP-CHD:leu1*^*+*^*acp2::bleMX*This workYSM3310*h90 myo52-tdTomato:natMX leu1-32:p*^*nmt41*^*-GFP-CHD:leu1*^*+*^*acp1::hphMX acp2::bleMX*This workYSM3311*h90 myo52-tdTomato:natMX fus1-sfGFP:kanMX*This workYSM3312*h90 myo52-tdTomato:natMX fus1-sfGFP:kanMX acp1::hphMX*This workYSM3313*h90 myo52-tdTomato:natMX fus1-sfGFP:kanMX acp2::bleMX*This workYSM3314*h90 myo52-tdTomato:natMX fus1-sfGFP:kanMX acp1::hphMX acp2::bleMX*This workYSM3315*h90 myo52-tdTomato:natMX leu1::p*^*nmt41*^*-GFP-cdc8:ura4*^*+*^This workYSM3316*h90 myo52-tdTomato:natMX leu1::p*^*nmt41*^*-GFP-cdc8:ura4*^*+*^*acp2::bleMX*This workYSM3317*h90 myo52-tdTomato:natMX fus1*^*K879A*^*-sfGFP:kanMX*This workYSM3318*h90 myo52-tdTomato:natMX fus1*^*I951A*^*-sfGFP:kanMX*This workYSM3319*h90 myo52-tdTomato:natMX fus1*^*GN1087,1088RP*^*-sfGFP:kanMX*This workYSM3320*h90 myo52-tdTomato:natMX fus1*^*K1112A*^*-sfGFP:kanMX*This workYSM3321*h90 myo52-tdTomato:natMX fus1*^*K879A*^*-sfGFP:kanMX acp2::bleMX*This workYSM3322*h90 myo52-tdTomato:natMX fus1*^*I951A*^*-sfGFP:kanMX acp2::bleMX*This workYSM3323*h90 myo52-tdTomato:natMX fus1*^*GN1087,1088RP*^*-sfGFP:kanMX acp2::bleMX*This workYSM3324*h90 myo52-tdTomato:natMX fus1*^*K1112A*^*-sfGFP:kanMX acp2::bleMX*This workYSM3325*h90 myo52-tdTomato:natMX acp2-sfGFP:kanMX fus1::hphMX*This workYSM3433*h90 myo52-tdTomato:natMX ura4-294:p*^*nmt1*^*-fus1-sfGFP:ura4*^*+*^This workYSM3328*h90 myo52-tdTomato:natMX exo84-GFP:kanMX*This workYSM3329*h90 myo52-tdTomato:natMX exo84-GFP:kanMX acp1::hphMX*This workYSM3330*h90 myo52-tdTomato:natMX exo84-GFP:kanMX acp2::bleMX*This workYSM3331*h90 myo52-tdTomato:natMX exo84-GFP:kanMX acp1::hphMX acp2::bleMX*This workYSM3332*h90 myo52-tdTomato:natMX exo70-GFP:kanMX*This workYSM3333*h90 myo52-tdTomato:natMX exo70-GFP:kanMX acp1::hphMX*This workYSM3334*h90 myo52-tdTomato:natMX exo70-GFP:kanMX acp2::bleMX*This workYSM3335*h90 myo52-tdTomato:natMX exo70-GFP:kanMX acp1::hphMX acp2::bleMX*This workYSM3336*h90 myo52-tdTomato:natMX ura4-294:p*^*nmt41*^*-GFP-ypt3:ura4*^*+*^This workYSM3337*h90 myo52-tdTomato:natMX ura4-294:p*^*nmt41*^*-GFP-ypt3:ura4*^*+*^*acp1::hphMX*This workYSM3338*h90 myo52-tdTomato:natMX ura4-294:p*^*nmt41*^*-GFP-ypt3:ura4*^*+*^*acp2::bleMX*This workYSM3339*h90 myo52-tdTomato:natMX ura4-294:p*^*nmt41*^*-GFP-ypt3:ura4*^*+*^*acp1::hphMX acp2::bleMX*This workYSM3340*h90 myo52-tdTomato:natMX agn2-sfGFP:kanMX*Lab StockYSM2571*h90 myo52-tdTomato:natMX agn2-sfGFP:kanMX acp1::hphMX*This workYSM3341*h90 myo52-tdTomato:natMX agn2-sfGFP:kanMX acp2::bleMX*This workYSM3342*h90 myo52-tdTomato:natMX agn2-sfGFP:kanMX acp1::hphMX acp2::bleMX*This workYSM3343*h90 myo52-tdTomato:natMX eng2-sfGFP:kanMX*Lab StockYSM2572*h90 myo52-tdTomato:natMX eng2-sfGFP:kanMX acp1::hphMX*This workYSM3344*h90 myo52-tdTomato:natMX eng2-sfGFP:kanMX acp2::bleMX*This workYSM3345*h90 myo52-tdTomato:natMX eng2-sfGFP:kanMX acp1::hphMX acp2::bleMX*This workYSM3346*h90 myo52-tdTomato:natMX*Lab StockYSM2440*h90 myo52-tdTomato:natMX myo51-sfGFP:kanMX*This workYSM3347*h90 myo52-tdTomato:natMX myo51-sfGFP:kanMX acp2::bleMX*This workYSM3348*h90 fim1-mCherry:natMX fus1-sfGFP:kanMX*This workYSM3349*h90 fim1-mCherry:natMX fus1-sfGFP:kanMX acp2::bleMX*This workYSM3350*h90 fim1-mCherry:natMX myo51-sfGFP:kanMX*This workYSM3351*h90 fim1-mCherry:natMX myo51-sfGFP:kanMX acp2::bleMX*This workYSM3352*h90 myo52-tdTomato:natMX acp1*^*Δtentacle*^*-sfGFP:kanMX*This workYSM3353*h90 myo52-tdTomato:natMX acp1-sfGFP:kanMX acp2::bleMX*This workYSM3354*h90 myo52-tdTomato:natMX acp2-sfGFP:kanMX*This workYSM3355*h90 myo52-tdTomato:natMX acp2*^*Δtentacle*^*-sfGFP:kanMX*This workYSM3356*h90 myo52-tdTomato:natMX acp2-sfGFP-kanMX acp1::hphMX*This workYSM3357*h90 myo52-tdTomato:natMX acp2*^*R12A,Y77A*^*-sfGFP:kanMX*This workYSM3358*h90 myo52-GFP:kanMX*Lab StockYSM2520*h90 myo52-GFP:kanMX fim1-GBP-mCherry:kanMX*This workYSM3359*h90 myo52-tdTomato:natMX fim1-sfGFP:kanMX*This workYSM3360*h90 myo52-tdTomato:natMX fim1-sfGFP:kanMX acp2::bleMX*This workYSM3361*h90 fim1-mCherry:natMX leu1::p*^*nmt41*^*-GFP-cdc8:ura4*^*+*^This workYSM3362*h90 fim1-mCherry:natMX leu1::p*^*nmt41*^*-GFP-cdc8:ura4*^*+*^*acp2::bleMX*This workYSM3363*h90 fim1-mCherry:natMX for3-3GFP:ura4*^*+*^This workYSM3364*h90 fim1-mCherry:natMX for3-3GFP:ura4*^*+*^*acp2::bleMX*This workYSM3365*h+ fim1-mCherry:natMX cdc12-3GFP:ura4*^*+*^This workYSM3366*h+ fim1-mCherry:natMX cdc12-3GFP:ura4*^*+*^*acp2::bleMX*This workYSM3367*h- leu1-32:p*^*act1*^*-LifeAct-mCherry:leu1*^*+*^Lab StockYSM3434*h- leu1-32:p*^*act1*^*-LifeAct-mCherry:leu1*^*+*^*acp2*^*R12A,Y77A*^*-sfGFP:kanMX*This workYSM3435*h- leu1-32:p*^*act1*^*-LifeAct-mCherry:leu1*^*+*^*acp1*^*Δtentacle*^*-sfGFP:kanMX*This workYSM3436*h- leu1-32:p*^*act1*^*-LifeAct-mCherry:leu1*^*+*^*acp2*^*Δtentacle*^*-sfGFP:kanMX*This workYSM3437*h- fim1-mCherry:natMX leu1::p*^*nmt41*^*-GFP-cdc8:ura4+ for3::bsd*This workYSM3368*h- fim1-mCherry:natMX leu1::p*^*nmt41*^*-GFP-cdc8:ura4+ for3::bsd acp2::bleMX*This workYSM3369*h- fim1-mCherry:natMX leu1::p*^*nmt41*^*-GFP-cdc8:ura4+ for3::kanMX cdc12-112*This workYSM3370*h- fim1-mCherry:natMX leu1::p*^*nmt41*^*-GFP-cdc8:ura4+ for3::kanMX cdc12-112 acp2::bleMX*This workYSM3371*h90 for3-3GFP:ura4*^*+*^*acp2-mCherry:natMX*This workYSM3438*h90 for3-3GFP:ura4*^*+*^*acp2-mCherry:natMX fim1::bleMX*This workYSM3439**Oligonucleotides**Primers for PCR, see [Table S1](#mmc1){ref-type="supplementary-material"}This workN/A**Recombinant DNA**pFA6a vector\[[@bib60]\]pSM644pFA6a-sfGFP-kanMX *(to generate Myo51-sfGFP, Fim1-sfGFP, acp1-sfGFP, acp1*^*Δt*^*-sfGFP, acp2-sfGFP and acp2*^*Δt*^*-sfGFP)*Lab StockpSM1538pFA6a-mCherry-natMX *(to generate Fim1-mCherry and Acp2-mCherry)*Lab StockpSM684pFA6a-GBP-mCherry-natMX *(to generate Fim1-GBP-mCherry)*Lab StockpSM1768pFA6a-hphMX *(to generate acp1Δ)*Lab StockpSM693pFA6a-bleMX *(to generate acp2Δ)*Lab StockpSM694pSP72 vectorPromegapSM1232pSP72-5′UTR-acp2-sfGFP-kanMX-3′UTRThis workpSM2194pSP72-5′UTR-acp2^R12A^-sfGFP-kanMX-3′UTRThis workpSM2201pSP72-5′UTR-acp2^R12AY77A^-sfGFP-kanMX-3′UTRThis workpSM2203pSP72-5′UTR-fus1-sfGFP-kanMX-3′UTRThis workpSM2218pSP72-5′UTR-fus1^K879A^-sfGFP-kanMX-3′UTRThis workpSM2251pSP72-5′UTR-fus1^I951A^-sfGFP-kanMX-3′UTRThis workpSM2252pSP72-5′UTR-fus1^GN1087,1088RP^-sfGFP-kanMX-3′UTRThis workpSM2253pSP72-5′UTR-fus1^K1112A^-sfGFP-kanMX-3′UTRThis workpSM2254pREP1 vectorLab StockpSM1758pUra4^AfeI^ vectorLab StockpAV133pUra4^AfeI^-p^nmt1^-fus1-sfGFPThis workpSM2282pREP41-GFP-ypt3Lab StockpSM893pUra4^AfeI^-pnmt41-GFP-ypt3This workpSM2250**Software and Algorithms**ImageJ (Fiji)NIHRRID: [SCR_002285](rridsoftware:SCR_002285){#intref0010}S. pombe database (released in August, 2013)PomBaseRRID: [SCR_006586](rridsoftware:SCR_006586){#intref0015}Image LabBio-RadRRID: [SCR_014210](rridsoftware:SCR_014210){#intref0020}VolocityPerkinElmerRRID: [SCR_002668](rridsoftware:SCR_002668){#intref0025}softWoRx v4.1.2Applied Precision, GE HealthcareNo direct downloadMATLABMathWorksRRID: [SCR_001622](rridsoftware:SCR_001622){#intref0030}

Lead Contact and Materials Availability {#sec4.2}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Sophie Martin (<sophie.martin@unil.ch>). Yeast strains generated in this study have not been deposited on an external repository but are available for distribution on request from the Lead Contact.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

*S. pombe* strains used in this study are listed in the [Key Resources Table](#sec4.1){ref-type="sec"}. Homothallic (h90) strains able to switch mating types were used for all mating experiments, where cells were grown in liquid or agar Minimum Sporulation Media (MSL), with or without nitrogen (+/− N) \[[@bib61], [@bib62]\]. For interphase experiments, cells were grown in liquid or agar Edinburgh minimal medium (EMM) supplemented with amino acids as required.

Method Details {#sec4.4}
--------------

### Strain Construction {#sec4.4.1}

Strains were constructed using standard genetic manipulation of *S. pombe* either by tetrad dissection or transformation.

With two exceptions (*cdc8* and *ypt3*), genes were tagged at their endogenous genomic locus at their 3′ end, yielding C-terminally tagged proteins, or deleted by replacing their ORF by a resistance cassette. This was achieved by PCR amplification of a fragment from a template plasmid with primers carrying 5′ extensions corresponding to the last 78 coding nucleotides of the ORF (for C-terminal tagging) or the last 78 nucleotides of the 5′UTR (for gene deletion) and the first 78 nucleotides of the 3′UTR, which was transformed and integrated in the genome by homologous recombination, as previously described \[[@bib60]\]. For tagging of genes with sfGFP, a pFA6a-sfGFP-kanMX plasmid (pSM1538) was used as a template for PCR-based targeted tagging of *myo51*, *fim1*, *acp1* and *acp2*. For tagging of genes with mCherry, a pFA6a-mCherry-natMX plasmid (pSM684) was used as a template for PCR-based targeted tagging of *fim1* and *acp2*. For tagging of genes with GBP-mCherry, a pFA6a-GBP-mCherry-natMX plasmid (pSM1768) was used as a template for PCR-based targeted tagging of *fim1*. For PCR-based targeted deletion, a pFA6a-hphMX plasmid (pSM693) or a pFA6a-bleMX plasmid (pSM694) was used as a template for *acp1* and *acp2* respectively. For deletion of the tentacle of Acp1 and Acp2, PCR-based targeted tagging was done using the last 78 nucleotides upstream of the C-terminal tentacle (R233-T256 for Acp1 and R244-I268 for Acp2). The functionality of the tagged proteins was verified by comparing the phenotype of the tagged strain with that of the deletion strain. For tagged Acp1 and Acp2 alleles, the number of ectopic foci was quantified and found to be as in wild-type cells. Reduced functionality was only observed for tagged Agn2 and Eng2 alleles, which in combination (but not individually) showed reduced fusion efficiency.

For point mutations of *acp2* (R12A-Y77A) and *fus1* (K879A, I951A, GN1087-1088RP, K1112A), a plasmid containing the full 5′UTR-ORF-sfGFP-kanMX-3′UTR sequence was first constructed by PCR amplification of the full fragment from strains YSM3312 or YSM3355 with primers carrying unique restriction sites, which were then cloned into a pSP72 plasmid (pSM1232). Site-directed mutagenesis was then conducted on these plasmids with primers containing the desired mutations. The resulting plasmids (pSM2203, pSM2251, pSM2252, pSM2253 and pSM2254, respectively) were sequenced, linearized and transformed into recipient strains YSM2440 for *acp2* and IBC178 (*fus1Δ* strain) for *fus1* mutants.

Construction of the strain overexpressing *fus1* (p^nmt1^-fus1-sfGFP) was done by integration of fus1-sfGFP under the *nmt1* promoter at the *ura4+* locus. First, the *nmt1* promotor was amplified from a pREP1 plasmid (pSM1758) with primers carrying KpnI and NotI extensions. Second, the fus1-sfGFP fragment was amplified from strain YSM3312 with primers carrying NotI and SacI extensions. These two fragments were cloned by 3-point ligation into the vector pAV133 (pJK211, a kind gift from Dr. Aleksandar Vjestica, UNIL) digested with KpnI and SacI. The resulting plasmid (pSM2282) was sequenced, digested with AfeI and stably integrated as a single copy at the *ura4+* locus into strain YSM2440.

Construction of the strain expressing ypt3 (p^nmt41^-GFP-ypt3) was done by integration of GFP-ypt3 under the *nmt41* promoter at the *ura4+* locus. The p^nmt41^-GFP-ypt3 fragment was digested from a pREP41-GFP-ypt3 plasmid (pSM893) with PstI and XmaI and cloned into the vector pAV133 digested with the same enzymes. The resulting plasmid (pSM2250) was linearized by AfeI and transformed into strain YSM2440. This construct is in principle similar to that published by Cheng et al. \[[@bib63]\], which was shown to rescue the *ypt3-i5* mutant phenotype. However, we note that we were unable to construct a GFP-ypt3 expressed as single copy from the native genomic locus, suggesting that GFP tagging impairs Ypt3 function.

The p^nmt41^-GFP-cdc8 construct is integrated at the *leu1* locus and was shown to rescue the *cdc8-110* mutant phenotypes \[[@bib64]\] (gratefully received from Prof David Kovar (Chicago University)). It is expressed in addition to the untagged *cdc8* gene copy at the endogenous genomic locus.

### Mating Assays {#sec4.4.2}

Live imaging of *S. pombe* mating cells protocol was adapted from \[[@bib62]\]. Briefly, cells were first pre-cultured overnight in MSL+N at 25°C, then diluted to OD~600~ = 0.05 into MSL+N at 25°C for 20 hours. Exponentially growing cells were then pelleted, washed in MSL-N by 3 rounds of centrifugation, and resuspended in MSL-N to an OD~600~ of 1.5. Cells were then grown 3 hours at 30°C to allow mating in liquid, added on 2% agarose MSL-N pads, and sealed with VALAP. We allowed the pads to rest for 30 min at 30°C before overnight imaging, or for 3 h before high speed imaging.

For interphase imaging, cells were grown to exponential phase at 30°C in EMM+ALU media, pelleted and added to 2% agarose EMM+ALU pads.

For CK-666 (Sigma) and LatA (Enzo Life Sciences) treatments, the drugs were added directly before imaging to the final resuspension, to a final concentration of 500μM and 200μM, respectively. In this case, cells were simply imaged without pad between slide and coverslip. The slide was allowed to rest for 5 minutes before imaging.

### Microscopy {#sec4.4.3}

Images presented in [Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, [5](#fig5){ref-type="fig"}, [S2](#mmc1){ref-type="supplementary-material"}, [S5](#mmc1){ref-type="supplementary-material"}C, and S5D, except [Figure 2](#fig2){ref-type="fig"}E were obtained using a DeltaVision platform (Applied Precision) composed of a customized inverted microscope (IX-71; Olympus), a UPlan Apochromat 100 × /1.4 NA oil objective, a camera (CoolSNAP HQ2 or 4.2Mpx PrimeBSI sCMOS camera; Photometrics), and a color combined unit illuminator (Insight SSI 7; Social Science Insights).

Figures were acquired using softWoRx v4.1.2 software (Applied Precision). Images were acquired every 5 minutes during 9 to 15 hours. To limit photobleaching, overnight videos were captured by optical axis integration (OAI) imaging of a 4.6-μm z section, which is essentially a real-time z-sweep.

Images presented in [Figures 4](#fig4){ref-type="fig"}, [6](#fig6){ref-type="fig"}, [S4](#mmc1){ref-type="supplementary-material"}, [S5](#mmc1){ref-type="supplementary-material"}A, [S6](#mmc1){ref-type="supplementary-material"}, and [2](#fig2){ref-type="fig"}E were obtained using a spinning-disk microscope composed of an inverted microscope (DMI4000B; Leica) equipped with an HCX Plan Apochromat 100 × /1.46 NA oil objective and an UltraVIEW system (PerkinElmer; including a real-time confocal scanning head \[CSU22; Yokagawa Electric Corporation\], solid-state laser lines, and an electron-multiplying charge coupled device camera \[C9100; Hamamatsu Photonics\]). Time-lapse images were acquired at 1 s interval using the Volocity software (PerkinElmer).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Fusion efficiencies were calculated as in \[[@bib42]\]. Briefly, at the specified time post-starvation, mating pairs and fused pairs were quantified using the ImageJ Plugin ObjectJ, and the subsequent fusion efficiency was calculated using the following equation:$$Fusion\ Efficiency\  = \ \frac{Fused\ Pairs\ }{Mating\ Pairs}\  \times 100$$Fusion Times were calculated using the 5-minutes time lapse overnight movies using the 2-dots Myo52-tdTomato stage \[[@bib42]\] as a marker for the beginning of the fusion process and either the entry of GFP expressed under control of the P-cell-specific *p*^*map3*^ promoter into the h- partner, or the maximum intensity of the Myo52-tdTomato dot, the two of which perfectly correlate \[[@bib42]\], as a marker for the end of the process. Persistence times were calculated using the 5-minutes time lapse overnight movies using fusion time as beginning and last appearance of the Myo52-tdTomato dot as end of the post-fusion focus lifetime. Fusion times and persistence times vary between experiments because, for all experiments but [Figures 1](#fig1){ref-type="fig"}A and 1C, only early time points were considered to avoid Myo52 bleaching, which most certainly induces a bias toward quickly fusing cells. The WT control was imaged and quantified for each experiment to allow comparison within an experiment.

Fusion Focus intensities at fusion time were obtained using the 5-minutes time lapse overnight movies using either the entry of GFP into the h-partner, or the maximum intensity of the Myo52-tdTomato dot to determine the moment of fusion. On that time frame, a fluorescence profile across the fusion focus perpendicular to the long axis of the mating pair was recorded.

Profiles were background-subtracted and corrected for bleaching as follows: First, the cell fluorescence intensity was recorded over time in a square of 7x7 pixels in 12 control (non-mating) cell. These fluorescence profiles were averaged, and the mean was fitted to a double exponential:$$Signal_{photobleaching - correction}\left( t \right) = Ae^{- Bt} + Ce^{- Dt}\ $$We then used this fit to correct the fluorescence profiles across the fusion focus for photobleaching. After subtracting background signal, the value at each time point was divided by the photo-bleaching correction signal:$$Signal_{BleachingCorrected} = \frac{\ \ Signal_{t}\ –\ Signal_{Background}}{\ Signal_{photobleaching - correction}\left( t \right)}$$Corrected profiles were then either directly averaged and plotted, or further normalized to the mean of the WT maximum.

Patch to cytosol ratios were calculated from the ratio of the mean fluorescence intensity of 5 circular ROIs centered on patches (which gives the patch intensity) to the mean fluorescence signal of 5 circular ROIs centered on cytosolic signal per cell. The same operation was repeated on 36 cells and plotted.

Total fluorescence intensities in mating pairs were obtained using single snapshots on regular slides, 7h post-starvation, by outlining the mating pairs and recoding the mean fluorescence intensity for each of them. Background fluorescence was assessed by a small square ROI in an area devoid of cells on each image, averaged over all images, and subtracted from fluorescence intensity measurements.

The number of ectopic foci was assessed using the 5-minutes time lapse overnight movies during the fusion process between the 2-dot stage and the fusion time by simply counting the number of time-frames showing an ectopic Myo52-tdTomato or any other marker. The numbers vary between experiments because the DeltaVision camera was upgraded in the middle of the project, allowing us to detect more delocalization events. To assess colocalization at ectopic foci, single and double-color ectopic foci were identified as above and the colocalization was calculated with the following formula:$$Percentage\ of\ Colocalization\  = \frac{2 \times EctopicFoci_{BothMarkers}}{EctopicFoci_{Marker1} + \ EctopicFoci_{Marker2}}\  \times 100$$The proportion of ectopic foci containing a given marker was derived from the ratio of ectopic foci containing the given marker to the total number, which gave a ratio for each cell. That ratio was then averaged over all the recorded cells. For all experiments shown in [Figure 6](#fig6){ref-type="fig"}, only ectopic foci present at the cell sides were considered.

For3-3GFP retrograde flow was identified by visual inspection of spinning disk time-lapse imaging acquired at 1 s interval. Only linear For3 dot movements present over at least 5 consecutive time frames were considered. Dots were manually tracked using the ImageJ multi-point tool and instantaneous speeds calculated and averaged per track. Kymographs were constructed using the ImageJ reslice tool along a 5-pixel-wide line along the For3 dot track.

All plots, fittings, corrections and normalizations were made using MATLAB home-made scripts. For boxplots, the central line indicates the median, the circle, if present, indicates the mean, and the bottom and top edges of the box indicate the 25th and 75th percentiles, respectively. The whiskers extend to the most extreme data points not considered outliers. For bar plots, error bars represent the standard deviation. Statistical p values were obtained using a two-sided t test, after normal distribution had been visually ckecked using a simple histogram. No further verification was made to ascertain that the data met assumptions of the statistical approach. All values below 0.05 are mentioned in the Figures, including sample size. Comparison with values above 0.05 are not shown ([Figure 1](#fig1){ref-type="fig"}A, *acp1Δ* and *acp1Δ acp2Δ* versus WT at 36h; [Figure 2](#fig2){ref-type="fig"}F, *fus1*^*G1087R,N1088P*^ *acp2Δ* versus *acp2+*; [Figure 3](#fig3){ref-type="fig"}F, Eng2-sfGFP in *acp2Δ* versus WT; [Figure 6](#fig6){ref-type="fig"}H). For all the supplementary figures, we consider, ^∗^ \< 5.10^−2^, ^∗∗^ \< 5.10^−5^, ^∗∗∗^ \< 5.10^−8^. All experiments were replicated at least 3 times. There was no pre-selection of sample size, nor randomization or blinding. No data was excluded from analysis.

Data and Code Availability {#sec4.6}
--------------------------

This study did not generate any substantial code or dataset.
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